Key Nuclear Medicine Market Players:
- GE HealthCare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Curium Pharma
- Lantheus Medical Imaging
- Bayer AG
- Siemens Healthineers
- Bracco Imaging
- Advanced Accelerator Applications (AAA)
- Cardinal Health
- Philips Healthcare
- Nordion Inc.
- Jubilant DraxImage
- PharmaLogic Holdings
- Eczacıbaşı-Monrol
- NTP Radioisotopes
- Life Molecular Imaging
- IBA (Ion Beam Applications)
- Nihon Medi-Physics
- Jubilant Pharmova (Lifesciences)
- Brightonix Imaging
- Mediso Ltd
The nuclear medicine market is primarily led by imaging and radiopharma companies like GE HealthCare, Siemens Healthineers, Curium and Lantheus. These companies are proactively positioning themselves to cement and expand their supply chain and technological advantages. Further, we see and expect rapid consolidation as pharmaceutical companies continue to invest in radioligand growth given the increase demand for theranostics. In the Asia-Pacific region, firms are focusing on an integrated model of cyclotron leasing, tracers, AI-assisted imaging, and clinical training to boost their footprint in the regional market.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2026, the industry size of nuclear medicine is assessed at USD 13.97 billion.
Nuclear Medicine Market size was valued at USD 12 billion in 2025 and is projected to reach USD 68.77 billion by the end of 2035, rising at a CAGR of 18.7% during the forecast period, i.e., 2026-2035.
North America is anticipated to capture the highest share of 43% in the global market by the end of 2035.
The major players in the market include GE HealthCare, Curium Pharma, Lantheus Medical Imaging, Bayer AG, Siemens Healthineers, Bracco Imaging, Advanced Accelerator Applications (AAA), Cardinal Health, Philips Healthcare, Nordion Inc., Jubilant DraxImage, PharmaLogic Holdings, Eczacıbaşı-Monrol, NTP Radioisotopes, Life Molecular Imaging, IBA (Ion Beam Applications), Nihon Medi-Physics, Jubilant Pharmova (Lifesciences), Brightonix Imaging, Mediso Ltd.
